Hirofumi TAKEUCHI - Search Results

Year	Number of Results
2002	4
2003	5
2004	8
2005	9
2006	2
2007	9
2008	10
2009	11
2010	13
2011	13
2012	12
2013	11
2014	3
2015	4
2016	9
2017	11
2018	7
2019	2
2020	5
2021	3
2022	2
2023	1
2024	0

1

[Particle Design Strategies for Developing Patient Centric Dosage Form Preparations].

Takeuchi H. Takeuchi H. Yakugaku Zasshi. 2020;140(8):1013-1024. doi: 10.1248/yakushi.20-00011. Yakugaku Zasshi. 2020. PMID: 32741859 Free article. Review. Japanese.

2

Oral protein delivery: a patent review of academic and industrial approaches.

Werle M, Makhlof A, Takeuchi H. Werle M, et al. Among authors: takeuchi h. Recent Pat Drug Deliv Formul. 2009 Jun;3(2):94-104. doi: 10.2174/187221109788452221. Recent Pat Drug Deliv Formul. 2009. PMID: 19519570 Review.

3

Modified chitosans for oral drug delivery.

Werle M, Takeuchi H, Bernkop-Schnürch A. Werle M, et al. Among authors: takeuchi h. J Pharm Sci. 2009 May;98(5):1643-56. doi: 10.1002/jps.21550. J Pharm Sci. 2009. PMID: 18781621 Review.

4

New-generation efflux pump inhibitors.

Werle M, Takeuchi H, Bernkop-Schnürch A. Werle M, et al. Among authors: takeuchi h. Expert Rev Clin Pharmacol. 2008 May;1(3):429-40. doi: 10.1586/17512433.1.3.429. Expert Rev Clin Pharmacol. 2008. PMID: 24422696

5

Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems.

Takeuchi H, Thongborisute J, Matsui Y, Sugihara H, Yamamoto H, Kawashima Y. Takeuchi H, et al. Adv Drug Deliv Rev. 2005 Nov 3;57(11):1583-94. doi: 10.1016/j.addr.2005.07.008. Epub 2005 Sep 16. Adv Drug Deliv Rev. 2005. PMID: 16169120 Review.

6

Hydroxypropyl-β-cyclodextrin Enhances Oral Absorption of Silymarin Nanoparticles Prepared Using PureNano™ Continuous Crystallizer.

Onodera R, Hayashi T, Motoyama K, Tahara K, Takeuchi H. Onodera R, et al. Among authors: takeuchi h. Pharmaceutics. 2022 Feb 10;14(2):394. doi: 10.3390/pharmaceutics14020394. Pharmaceutics. 2022. PMID: 35214124 Free PMC article.

7

[Development of gene delivery system using PLGA nanospheres].

Tahara K, Yamamoto H, Takeuchi H, Kawashima Y. Tahara K, et al. Among authors: takeuchi h. Yakugaku Zasshi. 2007 Oct;127(10):1541-8. doi: 10.1248/yakushi.127.1541. Yakugaku Zasshi. 2007. PMID: 17917416 Free article. Review. Japanese.

8

Particle design of poorly water-soluble drug substances using supercritical fluid technologies.

Yasuji T, Takeuchi H, Kawashima Y. Yasuji T, et al. Among authors: takeuchi h. Adv Drug Deliv Rev. 2008 Feb 14;60(3):388-98. doi: 10.1016/j.addr.2007.03.025. Epub 2007 Oct 11. Adv Drug Deliv Rev. 2008. PMID: 18068261 Review.

9

Design and evaluation of folate-modified liposomes for pulmonary administration in lung cancer therapy.

Onodera R, Morioka S, Unida S, Motoyama K, Tahara K, Takeuchi H. Onodera R, et al. Among authors: takeuchi h. Eur J Pharm Sci. 2022 Jan 1;168:106081. doi: 10.1016/j.ejps.2021.106081. Epub 2021 Nov 21. Eur J Pharm Sci. 2022. PMID: 34818571 Free article.

10

Effects of cationic liposomes with stearylamine against virus infection.

Tahara K, Kobayashi M, Yoshida S, Onodera R, Inoue N, Takeuchi H. Tahara K, et al. Among authors: takeuchi h. Int J Pharm. 2018 May 30;543(1-2):311-317. doi: 10.1016/j.ijpharm.2018.04.001. Epub 2018 Apr 3. Int J Pharm. 2018. PMID: 29625169

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

128 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Results by year